GLP-1 drugs effective for type 1 diabetes in new study| STAT
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Amgen obesity drug MariTide led to high discontinuation rates in trial
CHICAGO — Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects…
Study finds GLP-1 drug cut migraine frequency by nearly half
GLP-1 drugs could treat more than just diabetes and obesity. They may also reduce migraine frequency. That is…
Treatment that is tailored just for you – Life News
A new study, published in The New England Journal of Medicine in May this year, brought to light…